SLSNHIGH SIGNALFINANCIAL10-K

Sol sence (formerly Nanophase Technologies) underwent a corporate rebranding while experiencing a substantial decline in profitability despite revenue growth.

The company's operating income fell meaningfully while revenue grew 18.6%, indicating significant margin compression and operational challenges during the transition period. The substantial increase in SG&A expenses to $10.4M suggests elevated costs associated with the rebranding initiative and business transformation may be pressuring near-term profitability.

Comparing 2026-03-31 vs 2025-03-31View on EDGAR →
FINANCIAL ANALYSIS

Sol sence delivered solid revenue growth of 18.6% to $62.1M, accompanied by a 40% increase in accounts receivable and improved stockholder equity of $17.6M. However, operating performance deteriorated substantially as SG&A expenses grew notably to $10.4M, resulting in compressed operating margins and reduced net income. The 46% reduction in current liabilities suggests improved working capital management, though this was insufficient to offset the margin pressure from elevated operating expenses during the corporate transformation.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
-69.4%
$5.1M$1.6M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Net Income
P&L
-57.7%
$4.2M$1.8M

Net income declined 57.7% — review whether driven by operations, interest costs, or non-recurring items.

Current Liabilities
Balance Sheet
-46%
$25.8M$13.9M

Current liabilities reduced — improved short-term financial position and working capital health.

SG&A Expense
P&L
+44.1%
$7.2M$10.4M

SG&A up 44.1% — significant increase in sales or administrative costs, monitor impact on operating leverage.

Accounts Receivable
Balance Sheet
+40.4%
$4.9M$6.8M

Receivables surged 40.4% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.

Revenue
P&L
+18.6%
$52.3M$62.1M

Revenue growing 18.6% — solid top-line momentum, watch margins for quality of growth.

Stockholders Equity
Balance Sheet
+18%
$14.9M$17.6M

Equity base grew 18% — retained earnings accumulation or equity issuance strengthening the balance sheet.

LANGUAGE CHANGES
NEW — 2026-03-31
PRIOR — 2025-03-31
ADDED
Employer Identification No.) of incorporation or organization) 1319 Marquette Drive , Romeoville , Illinois 60446 (Address of principal executive offices) (zip code) Registrant s telephone number, including area code: (630) 771-6708 SOLESENCE, INC.
General Company Background On March 7, 2025, Nanophase Technologies Corporation announced its rebranding as Sol sence, Inc.
( Sol sence, Company, we, our, or us ), marking a new chapter in its commitment to skin health innovation and consumer products across beauty, health, and wellness categories.
Our corporate website has transitioned to solesence.com and investor relations information, including historical Nanophase financials and disclosures, is available at ir.solesence.com.
Nanophase Technologies Corporation changed its legal name to Sol sence, Inc.
+7 more — sign up free →
REMOVED
See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.
General Company Background On March 7, 2025, Nanophase Technologies Corporation announced its rebranding as Solesence, Inc.
( Sol sence, Company, we, our, or us ), marking a new chapter in its commitment to innovation, self-expression, and inclusivity in skin health.
The company s stock will continue to trade under the NANX ticker symbol.
Investor relations information, including historic Nanophase financials and disclosures, is available at ir.solesence.com.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →